ispronicline experimental drug acts partial agonist neural nicotinic acetylcholine receptors progressed phase ii clinical trials treatment dementia alzheimers disease longer also progressed phase ii potential treatment adhd dosages mgday showing significant improvement adhd ispronicline subtypeselective binding primarily subtype antidepressant nootropic neuroprotective effectsmedical citation needed early stage clinical trials showed ispronicline well tolerated main side effects dizziness however midstage clinical trials failed show sufficient efficacy continue development pharmaceutical drug article relating nervous system stub help wikipedia expanding httpsenwikipediaorgwikiispronicline